• 1
    Sutton BM, McGusty E, Walz DT, DiMartino MJ: Oral gold: antiarthritic properties of alkylphosphinegold co-ordination complexes. J Med Chem 15: 10951098, 1972
  • 2
    Walz DT, DiMartino MJ, Chakrin LW, Sutton BM, Misher A: Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: SK&F D-39162. J Pharmacol Exp Ther 197: 142152, 1976
  • 3
    Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Misher A: Auranofin—new oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis 35: 251257, 1976
  • 4
    Berglof F, Berglof K, Walz DT: Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. J Rheumatol 5: 6874, 1978
  • 5
    Weisman MH, Hannifin DM: Management of rheumatoid arthritis with oral gold. Arthritis Rheum 22: 922925, 1979
  • 6
    Finkelstein AE, Roisman FR, Batista V, Nudelman FG, de Titto EH, Mizraji M, Walz DT: Oral chrysotherapy in rheumatoid arthritis: minimum effective dose. J Rheumatol 7: 160168, 1980
  • 7
    Bernhard GC: Auranofin treatment for adult rheumatoid arthritis: comparison of 2 mg and 6 mg daily dose. J Rheumatol (suppl) 9: 149153, 1982
  • 8
    Bandilla K, Gross D, Gross W, Herrlinger JD, Kriegel W, Muller H, Siegmeth W, Tausch G, Thumb N, Wagenhauser FK: Oral gold therapy with auranofin (SK&F 39162): a multicenter open study in patients with rheumatoid arthritis. J Rheumatol (suppl) 9: 154159, 1982
  • 9
    Champion GD, Bieri D, Browne CD, Day RO, Graham GG, Haavisto TM, Sambrook P, Vallance JB: Auranofin in rheumatoid arthritis. J Rheumatol (suppl) 9: 137145, 1982
  • 10
    Menard HA, Beaudet F, Davis P, Harth M, Percy JS, Russell AS, Thompson JM: Gold therapy in rheumatoid arthritis: interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. J Rheumatol (suppl) 9: 179183, 1982
  • 11
    Katz WA, Alexander S, Bland JH, Blechman W, Bluhm GB, Bonebrake RA, Falbo A, Greenwald RA, Hartman S, Hobbs T, Indenbaum S, Lergier JE, Lanier BG, Lightfoot RW, Phelps P, Sheon RP, Torretti D, Wenger ME, Wilske K: The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. J Rheumatol (suppl) 9: 173178, 1982
  • 12
    Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H: Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis, a double-blind, comparative, multicenter study. J Rheumatol (suppl) 9: 184189, 1982
  • 13
    Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 14
    Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR: Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148159, 1972
  • 15
    The Cooperating Clinics Committee of the American Rheumatism Association: A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 8: 302334, 1965
  • 16
    Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949
  • 17
    Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24: 13081315, 1981
  • 18
    Kamel H, Brown DH, Ottaway JM, Smith WE: Determination of gold in blood fractions by atomic-absorption spectrometry using carbon rod and carbon furnace atomisation. Analyst 101: 790797, 1976
  • 19
    Schattenkirchner M, Grobenski Z: The measurement of gold in blood and urine by atomic absorption in the treatment of rheumatoid arthritis. Atomic Absorption Newsletter 16: 8488, 1977
  • 20
    Landis JR, Heyman ER, Koch GG: Average partial association in three-way contingency tables: a review and discussion of alternative tests. Intern Stat Rev 46: 237254, 1978
  • 21
    Hutchison RM, David P, Jayson MIV: Thrombocytosis in rheumatoid arthritis. Ann Rheum Dis 35: 138142, 1976
  • 22
    The Research Sub-Committee of the Empire Rheumatism Council: Gold therapy in rheumatoid arthritis: report of a multi-centre controlled trial. Ann Rheum Dis 19: 95119, 1960
  • 23
    The Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 16: 353358, 1973
  • 24
    Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR: Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Ann Intern Med 80: 2126, 1974
  • 25
    Editorial: Gold therapy in 1975. Br Med J 2: 156157, 1975
  • 26
    Winterbauer RH, Wilske KR, Wheeler RF: Diffuse pulmonary injury associated with gold treatment. N Engl J Med 294: 919921, 1976
  • 27
    Gould PW, McCormack PL, Palmer DG: Pulmonary damage associated with sodium aurothiomalate therapy. J Rheumatol 4: 252260, 1977
  • 28
    Favreau M, Tannenbaum H, Lough J: Hepatic toxicity associated with gold therapy. Ann Intern Med 87: 717719, 1977
  • 29
    Kaplinsky N, Pras M, Frankl O: Severe enterocolitis complicating chrysotherapy. Ann Rheum Dis 32: 574577, 1973
  • 30
    Stein HB, Urowitz MB: Gold-induced enterocolitis: case report and literature review. J Rheumatol 3: 2126, 1976
  • 31
    Fam AG, Paton TW, Shamess CJ, Lewis AJ: Fulminant colitis complicating gold therapy. J Rheumatol 7: 479484, 1980
  • 32
    Gerber RC, Paulus HE, Bluestone R, Pearson CM: Clinical response and serum gold levels in chrysotherapy: lack of correlation. Ann Rheum Dis 31: 308310, 1972
  • 33
    Mascarenhas BR, Granda JL, Freyberg RH: Gold metabolism in patients with rheumatoid arthritis treated with gold compounds—reinvestigated. Arthritis Rheum 15: 391402, 1972
  • 34
    Rubinstein HM, Dietz AA: Serum gold. II. Levels in rheumatoid arthritis. Ann Rheum Dis 32: 128132, 1973
  • 35
    Jessop JD, Johns RGS: Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate. Ann Rheum Dis 32: 228232, 1973
  • 36
    Gottlieb NL, Smith PM, Smith EM: Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood: correlations with course of rheumatoid arthritis, gold toxicity and gold excretion. Arthritis Rheum 17: 171183, 1974
  • 37
    Bluhm GB: The treatment of rheumatoid arthritis with gold. Semin Arthritis Rheum 5: 147166, 1975
  • 38
    Furst DE, Levine S, Srinivasan R, Metzger AL, Bangert R, Paulus HE: A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis. Arthritis Rheum 20: 14731480, 1977